BioDelivery Sciences International, Inc. (BDSI) was a big mover last session, as its shares rose almost 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the downtrend for the company since Sep 2, as the stock is now down nearly 2%.
In the last 30 days, the company witnessed a mixed track record of three positive and two negative estimate revisions. Meanwhile, the Zacks Consensus Estimate moved lower, signaling trouble down the road. So make sure to keep an eye on this stock going forward to see if Friday’s move higher can last.
BioDelivery Sciences International currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Other better-ranked stocks in the biomedical/gene industry include Gilead Sciences Inc. (GILD), Cambrex Corporation. (CBM) and China Biologic Products, Inc. (CBPO). All three sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment